The CMO's sales follow derivative exercises and are consistent with routine tax-related selling. The General Counsel's sale is a single open-market transaction. Without a pattern of aggressive selling or a material percentage of market cap, this cluster does not signal negative information. Monitor for any subsequent insider buying or a material increase in selling volume.
Price Chart
Executive Summary
Two insiders at Oruka Therapeutics sold a total of $534K in open-market sales within a week. The CMO exercised and sold shares at prices between $73.89 and $78.79, while the General Counsel sold at $78.79. The total value is modest relative to the company's market cap, and the sales appear to be routine post-exercise diversification rather than a bearish signal.
Key Financial Metrics
Key Facts
- CMO Goncalves Joana sold 2,853 shares at $73.89, 1,847 shares at $74.69, 1,400 shares at $75.48, 700 shares at $76.67, and 200 shares at $77.71 on 2026-10-15, totaling ~$524K in open-market sales.
- CMO also exercised derivative securities at $6.84, $7.80, and $0 (non-cash) on the same day, indicating the sales were likely to cover exercise costs and taxes.
- General Counsel Paul Quinlan sold 4,100 shares at $78.79 on 2026-10-20 for $323K.
- Total insider sales of $534K represent a small fraction of market cap (likely <0.2%), well below the 0.5% threshold for materiality.
- No insider open-market purchases were reported in the cluster.
Financial Impact
Total insider sales of $534K, likely less than 0.2% of market cap. No material financial impact.
Risk Factors
- Insider selling could accelerate if the stock continues to rise, but no evidence of coordinated bearish activity.
- No insider buying to offset the selling, which may indicate lack of conviction at current levels.
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ORKA-1792543373777 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | — | awaiting T+5 | — | — |
Oct 25, 2026 1d ago | Press Release | $80.15 | awaiting T+5 | — | $90.33 (+12.70%) |
Oct 20, 2026 5d ago | Insider Cluster | $79.92 | awaiting T+5 | — | $90.33 (+13.03%) |
Oct 15, 2026 10d ago | Insider Cluster | $71.93 $80.15 | ▲ +11.43% | ▲ +11.86% | $90.33 (+25.58%) |
Sep 21, 2026 4w ago | Insider Cluster | $94.55 $82.15 | ▲ +13.11% | ▲ +11.93% | $90.33 (+4.46%) |
Sep 15, 2026 5w ago | Insider Cluster | $93.55 $89.93 | ▼ −3.87% | ▼ −6.44% | $90.33 (−3.44%) |
Sep 1, 2026 7w ago | Insider Cluster | $91.63 $91.65 | ▼ −0.02% | ▼ −0.98% | $90.33 (+1.42%) |
Aug 28, 2026 8w ago | EFFECT | $91.15 $92.51 | ▼ −1.50% | ▼ −1.39% | $90.33 (+0.89%) |
Aug 17, 2026 9w ago | Insider Cluster | $113.08 $101.82 | ▼ −9.96% | ▼ −9.76% | $90.33 (−20.12%) |
Aug 10, 2026 11w ago | Press Release | $105.14 $112.66 | ▲ +7.15% | ▲ +7.20% | $90.33 (−14.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers